72 related articles for article (PubMed ID: 10786233)
1. [Trials and perspectives in pharmacotherapy of Alzheimer's disease].
Kieszek S
Psychiatr Pol; 1999; 33(3):331-40. PubMed ID: 10786233
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of Alzheimer's disease].
López OL; Becker JT
Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
[TBL] [Abstract][Full Text] [Related]
4. The mechanisms of neurodegenerative processes and current pharmacotherapy of Alzheimer's disease.
Gongadze N; Antelava N; Kezeli T; Okudjava M; Pachkoria K
Georgian Med News; 2008 Feb; (155):44-8. PubMed ID: 18401056
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment of Alzheimer's disease: an update.
DeLaGarza VW
Am Fam Physician; 2003 Oct; 68(7):1365-72. PubMed ID: 14567491
[TBL] [Abstract][Full Text] [Related]
6. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
Grossberg GT
Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
8. New developments in the treatment of Alzheimer's disease.
J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
[No Abstract] [Full Text] [Related]
9. [Perspectives of therapy of Alzheimer's disease].
Sienkiewicz-Jarosz H; Kostowski W
Psychiatr Pol; 2000; 34(4):623-40. PubMed ID: 11059261
[TBL] [Abstract][Full Text] [Related]
10. Disease-modifying approaches to Alzheimer's disease: challenges and opportunities-Lessons from donepezil therapy.
Sabbagh MN; Richardson S; Relkin N
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S109-18. PubMed ID: 18631986
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
12. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
Pákáski M; Kálmán J
Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
[TBL] [Abstract][Full Text] [Related]
13. [Research progress on Alzheimer's disease: pathogenesis and medical therapy].
Sheng SL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):101-3. PubMed ID: 15171541
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.
Bruno MA; Leon WC; Fragoso G; Mushynski WE; Almazan G; Cuello AC
J Neuropathol Exp Neurol; 2009 Aug; 68(8):857-69. PubMed ID: 19606067
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G
Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
18. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.
Mufson EJ; Ikonomovic MD; Styren SD; Counts SE; Wuu J; Leurgans S; Bennett DA; Cochran EJ; DeKosky ST
Arch Neurol; 2003 Aug; 60(8):1143-8. PubMed ID: 12925373
[TBL] [Abstract][Full Text] [Related]
19. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
Doody RS
J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological basis of drug therapy of Alzheimer's disease.
Sharma A; Parikh V; Singh M
Indian J Exp Biol; 1997 Nov; 35(11):1146-55. PubMed ID: 9567741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
